(Q74126218)

English

Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status

scientific article published on 01 April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

author name string

J L Mccoy

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Rucker

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J A Petros

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 April 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

60

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

227-234

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930110%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

https://scigraph.springernature.com/pub.10.1023/a:1006405504158

0 references

Predicting recurrence and survival in breast cancer. A panel discussion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer of the breast: Size of neoplasm and prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of lymphocyte immunity in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer prognosis predicted by preoperative lymphocyte responsiveness in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor marker kinetics in the monitoring of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-Mediated Immune Responses of Breast Cancer Patients to Autologous Tumor-Associated Antigens2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006405504158

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74126218&oldid=2073193632"